Wed, Mar 4, 2015, 3:24 PM EST - U.S. Markets close in 36 mins.


% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • stockerapproach stockerapproach Jun 19, 2013 10:05 AM Flag

    UBS started INSM at buy 6/18/2013 ...DowJones newswire.........Good luck people.

    FROM Etrade:

    Insmed Started at Buy by UBS INSM

    Jun 18, 2013 08:07:22 (ET)

    (END) Dow Jones Newswires

    June 18, 2013 08:07 ET (12:07 GMT)

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • From Seeking Alpha:

      11:27 AM UBS initiates Insmed (INSM +0.7%) at Buy with a $17.50 price target representing a 37% upside. Arikace "has a solid chance of success in its primary indication of cystic fibrosis," analyst Matthew Harrison says, adding that the "underappreciated" non-tuberculous mycobacteria opportunity could be another growth catalyst going forward. (Previous: Arikace's NTM indication possibly more compelling than CF opportunity) Read comments

      INSM price at time of publication: $12.87. Check INSM price now »

19.015+0.595(+3.23%)3:23 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.